Contraindicated (one)pentobarbital will lower the extent or effect of lumefantrine by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Contraindicated. Coadministration with robust CYP3A4 inducers may end up in lessened serum concentrations and loss of antimalarial efficacy Intramuscular